{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:31:44Z","timestamp":1788496304575,"version":"build-2803163510"},"reference-count":46,"publisher":"Bioscientifica","issue":"6","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":279,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270938, 81970757, 81900811"],"award-info":[{"award-number":["82270938, 81970757, 81900811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"crossref","award":["2021YFC2501700"],"award-info":[{"award-number":["2021YFC2501700"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["CIFMS-2021-I2M-1-002"],"award-info":[{"award-number":["CIFMS-2021-I2M-1-002"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Short stature is a characteristic of X-linked hypophosphatemia (XLH). We aim to explore the factors that influence the height of pre-pubertal children with XLH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on a randomized clinical trial of high\/low doses of active vitamin D with neutral phosphate treatment for XLH children, we recruited 124 pre-pubertal children with XLH, and 46 participants completed the 24-month follow-up. Participants were separated into the short stature (height Z score &amp;lt; \u22122) and non-short stature groups (height Z score \u2265 \u22122). Height, medication history, biochemical parameters, the Thacher Rickets Severity Score (RSS), and bone age were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, 50.8% of participants were short stature. The height Z score of males (\u22122.35 \u00b1 1.18) was significantly lower than that of females (\u22121.86 \u00b1 1.03), P = 0.014. The height Z score had negative correlations with age when enrolled, initial age of medication, and RSS (\u03b2: \u22120.327\u223c\u22120.251, P &amp;lt; 0.01), but had a positive correlation with calcium-phosphorus product (\u03b2: 0.213, P = 0.015). Compared to the non-short stature group, the proportion of delayed bone age was higher in the short stature group (10.0 vs 42.9%, P &amp;lt; 0.001). At the 24-month follow-up, the median height Z score increased from \u22121.91 to \u22121.74 (P = 0.002), whose improvement had no significant differences between groups of male\/female, high\/low doses of calcitriol, and non-truncating\/truncating variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In pre-pubertal children with XLH, a higher height Z score has associations with females, early initiation of treatment, better bone mineralization, and milder rachitic lesions. Conventional therapy improves their heights, but the efficacy does not depend on sex, active vitamin D dosage, or variant type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-24-0605","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T08:30:49Z","timestamp":1746606649000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Short stature in pre-pubertal children with X-linked hypophosphatemia"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-6778","authenticated-orcid":true,"given":"Hanting","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]},{"name":"Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine 2 , , ,","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]},{"name":"Department of Endocrinology and Metabolism, Beijing Tsinghua Changgung Hospital, Tsinghua University 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]},{"name":"Department of Endocrinology, China-Japan Friendship Hospital 4 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosen","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Jiajue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University; Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism; Shandong Institute of Endocrine & Metabolic Disease 5 , , ,","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 1 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"2026070710590689800_bib1","article-title":"Consensus recommendations for the diagnosis and management of X-linked hypophosphatemia in Belgium","volume":"12","author":"Laurent","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070710590689800_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium","volume":"11","author":"Francis","year":"1995","journal-title":"Nat Genet"},{"key":"2026070710590689800_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.24296","article-title":"Novel PHEX gene locus-specific database: comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH)","volume":"43","author":"Sarafrazi","year":"2022","journal-title":"Hum Mutat"},{"key":"2026070710590689800_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"2026070710590689800_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary management of FGF23-related phosphate wasting syndromes: a consensus statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026070710590689800_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13023-021-01729-0","article-title":"Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population","volume":"16","author":"Rodr\u00edguez-Rubio","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2026070710590689800_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12098-014-1609-y","article-title":"Approach to short stature","volume":"82","author":"Yadav","year":"2015","journal-title":"Indian J Pediatr"},{"key":"2026070710590689800_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ghir.2017.12.003","article-title":"Genetic short stature","volume":"38","author":"Grunauer","year":"2018","journal-title":"Growth Horm IGF Res"},{"key":"2026070710590689800_bib9","article-title":"Clinical and genetic characteristics of 153 Chinese patients with X-linked hypophosphatemia","volume":"9","author":"Lin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026070710590689800_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2019.01.021","article-title":"Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia","volume":"121","author":"Zhang","year":"2019","journal-title":"Bone"},{"key":"2026070710590689800_bib11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00198-021-06221-w","article-title":"The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study","volume":"33","author":"Jin","year":"2022","journal-title":"Osteoporos Int"},{"key":"2026070710590689800_bib12","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"2026070710590689800_bib13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/ijms23020934","article-title":"Cellular and molecular alterations underlying abnormal bone growth in X-linked hypophosphatemia","volume":"23","author":"Fuente","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026070710590689800_bib14","first-page":"119","article-title":"Spontaneous growth and effect of early therapy with calcitriol and phosphate in X-linked hypophosphatemic rickets","volume":"15","author":"Cagnoli","year":"2017","journal-title":"Pediatr Endocrinol Rev"},{"key":"2026070710590689800_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00467-010-1705-9","article-title":"Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets","volume":"26","author":"Zivi\u010dnjak","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"2026070710590689800_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","article-title":"Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment","volume":"27","author":"Quinlan","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2026070710590689800_bib17","volume-title":"StatPearls","author":"Emmanuel"},{"key":"2026070710590689800_bib18","first-page":"487","article-title":"[Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2026070710590689800_bib19","first-page":"493","article-title":"[Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years]","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2026070710590689800_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","article-title":"Radiographic scoring method for the assessment of the severity of nutritional rickets","volume":"46","author":"Thacher","year":"2000","journal-title":"J Trop Pediatr"},{"key":"2026070710590689800_bib21","volume-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","edition":"2nd edn"},{"key":"2026070710590689800_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11154-017-9408-1","article-title":"X-linked hypophosphatemia and growth","volume":"18","author":"Fuente","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"2026070710590689800_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116791","article-title":"Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: results from the Australian and the New Zealand paediatric surveillance units survey","volume":"173","author":"Sandy","year":"2023","journal-title":"Bone"},{"key":"2026070710590689800_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"2026070710590689800_bib25","volume-title":"Xiangya Metabolic Osteology","author":"Liao","year":"2013"},{"key":"2026070710590689800_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"2026070710590689800_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF00868733","article-title":"Stimulation of growth hormone secretion in children with X-linked hypophosphatemia","volume":"9","author":"Seikaly","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"2026070710590689800_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/eje.0.1490317","article-title":"Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency","volume":"149","author":"Sch\u00fctt","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2026070710590689800_bib29","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-021-05328-w","article-title":"Rickets guidance: part I-diagnostic workup","volume":"37","author":"Haffner","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"2026070710590689800_bib30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/jbmr.5650101112","article-title":"Serum insulin-like growth factor binding protein-3 in the hypophosphatemic mouse: decreased activity and abnormal modulation by dietary phosphate","volume":"10","author":"Moriwake","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2026070710590689800_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-21-0429","article-title":"Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia","volume":"185","author":"Zhukouskaya","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026070710590689800_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bone.2019.02.010","article-title":"Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: utility of the radiographic Rickets Severity Score","volume":"122","author":"Thacher","year":"2019","journal-title":"Bone"},{"key":"2026070710590689800_bib33","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"2026070710590689800_bib34","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00467-022-05484-7","article-title":"Real-world effectiveness of burosumab in children with X-linked hypophosphatemic rickets","volume":"37","author":"Paloian","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"2026070710590689800_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00223-013-9736-4","article-title":"Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia","volume":"93","author":"Ichikawa","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"2026070710590689800_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.699767","article-title":"Genotype and phenotype analysis in X-linked hypophosphatemia","volume":"9","author":"Park","year":"2021","journal-title":"Front Pediatr"},{"key":"2026070710590689800_bib37","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","article-title":"Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes","volume":"102","author":"Sabbagh","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070710590689800_bib38","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026070710590689800_bib39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bone.2003.12.015","article-title":"Cartilage abnormalities are associated with abnormal Phex expression and with altered matrix protein and MMP-9 localization in Hyp mice","volume":"34","author":"Miao","year":"2004","journal-title":"Bone"},{"key":"2026070710590689800_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1359\/jbmr.2002.17.2.311","article-title":"Ontogeny of Phex\/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts","volume":"17","author":"Thompson","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2026070710590689800_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bone.2018.08.004","article-title":"Marked alterations in the structure, dynamics and maturation of growth plate likely explain growth retardation and bone deformities of young Hyp mice","volume":"116","author":"Fuente","year":"2018","journal-title":"Bone"},{"key":"2026070710590689800_bib42","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/clinem\/dgaa495","article-title":"Growth curves for children with X-linked hypophosphatemia","volume":"105","author":"Mao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710590689800_bib43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13023-022-02590-5","article-title":"Growth hormone treatment improves final height in children with X-linked hypophosphatemia","volume":"17","author":"Andr\u00e9","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2026070710590689800_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)","volume":"36","author":"Rothenbuhler","year":"2017","journal-title":"Growth Horm IGF Res"},{"key":"2026070710590689800_bib45","doi-asserted-by":"crossref","first-page":"E2097","DOI":"10.1210\/jc.2011-0399","article-title":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion","volume":"96","author":"\u017divi\u010dnjak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710590689800_bib46","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1542\/peds.113.6.e593","article-title":"Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets","volume":"113","author":"Haffner","year":"2004","journal-title":"Pediatrics"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/6\/EC-24-0605.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/6\/EC-24-0605.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0605\/9550\/ec-24-0605.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0605\/9550\/ec-24-0605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:26:30Z","timestamp":1783437990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/6\/e240605\/1400\/Short-stature-in-pre-pubertal-children-with-X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0605","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"article-number":"e240605"}}